.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
QuintilesIMS
Chubb
US Army
UBS
Novartis
Queensland Health
Johnson and Johnson
Fuji
Deloitte

Generated: June 28, 2017

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: insulin glargine

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Eli Lilly And Co
BASAGLAR
insulin glargine
SOLUTION;SUBCUTANEOUS205692NDAEli Lilly and Company0002-7715-595 SYRINGE in 1 CARTON (0002-7715-59) > 3 mL in 1 SYRINGE (0002-7715-01)
Eli Lilly And Co
BASAGLAR
insulin glargine
SOLUTION;SUBCUTANEOUS205692NDAEli Lilly and Company0002-7715-631 SYRINGE in 1 CARTON (0002-7715-63) > 3 mL in 1 SYRINGE
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Chubb
US Department of Justice
Medtronic
Baxter
Harvard Business School
Colorcon
QuintilesIMS
Citi
Johnson and Johnson

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot